Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response
Conclusions: The exposure-matching analysis permitted approval of an esomeprazole regimen not studied directly in clinical trials. Exposure-response for intragastric pH-permitted approval for the treatment of gastroesophageal reflux disease in children in whom it was not possible to evaluate the adult primary endpoint, mucosal healing assessed by endoscopy.
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research
More News: Acid Reflux | Children | Clinical Trials | Endoscopy | Esomeprazole | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Nexium | Nutrition | Pediatrics